2020. Demographics, Prior Therapies, and Reasons for Cemiplimab Treatment: Prospective CemiplimAb-rwlc Survivorship and Epidemiology (C.A.S.E.) Study in Patients with Advanced Cutaneous Squamous Cell Carcinoma. SKIN The Journal of Cutaneous Medicine. 4, 6 (Oct. 2020), s125. DOI:https://doi.org/10.25251/skin.4.supp.125.